Ballentine Partners LLC Raises Holdings in CME Group Inc. (NASDAQ:CME)

Posted by Defense World Staff on Apr 10th, 2023

Ballentine Partners LLC increased its position in CME Group Inc. (NASDAQ:CME – Get Rating) by 4.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,196 shares of the financial services provider’s stock after buying an additional 162 shares during the period. Ballentine Partners LLC’s holdings in CME Group were worth $706,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CME. M&G Investment Management Ltd. boosted its position in shares of CME Group by 17.8% during the 4th quarter. M&G Investment Management Ltd. now owns 489,096 shares of the financial services provider’s stock valued at $82,168,000 after acquiring an additional 74,021 shares during the last quarter. State of Michigan Retirement System raised its stake in CME Group by 0.5% during the fourth quarter. State of Michigan Retirement System now owns 97,744 shares of the financial services provider’s stock valued at $16,437,000 after purchasing an additional 500 shares in the last quarter. Paradigm Financial Partners LLC lifted its position in CME Group by 2.9% during the fourth quarter. Paradigm Financial Partners LLC now owns 13,060 shares of the financial services provider’s stock valued at $2,287,000 after purchasing an additional 365 shares during the last quarter. Baldwin Brothers LLC MA grew its stake in shares of CME Group by 10.7% in the 4th quarter. Baldwin Brothers LLC MA now owns 880 shares of the financial services provider’s stock worth $148,000 after buying an additional 85 shares in the last quarter. Finally, Close Asset Management Ltd increased its holdings in shares of CME Group by 14.8% in the 4th quarter. Close Asset Management Ltd now owns 1,085 shares of the financial services provider’s stock worth $182,000 after buying an additional 140 shares during the last quarter. 85.09% of the stock is owned by institutional investors.

CME Group Stock Down 0.0 %

Shares of NASDAQ CME opened at $195.10 on Monday. CME Group Inc. has a 52-week low of $166.54 and a 52-week high of $247.01. The firm has a market capitalization of $70.18 billion, a price-to-earnings ratio of 26.40, a PEG ratio of 6.22 and a beta of 0.41. The stock has a 50 day moving average price of $184.59 and a 200 day moving average price of $177.93. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.01 and a current ratio of 1.01.

CME Group (NASDAQ:CME – Get Rating) last issued its earnings results on Wednesday, February 8th. The financial services provider reported $1.92 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.02. The business had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.21 billion. CME Group had a return on equity of 10.43% and a net margin of 53.61%. The business’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period in the prior year, the business earned $1.66 EPS. Sell-side analysts expect that CME Group Inc. will post 8.46 earnings per share for the current year.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 27th. Shareholders of record on Friday, March 10th were issued a dividend of $1.10 per share. This represents a $4.40 annualized dividend and a yield of 2.26%. This is a boost from CME Group’s previous quarterly dividend of $1.00. The ex-dividend date of this dividend was Thursday, March 9th. CME Group’s dividend payout ratio is presently 59.54%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on CME shares. Oppenheimer lowered their price target on shares of CME Group from $218.00 to $213.00 and set an “outperform” rating for the company in a report on Thursday, January 19th. Deutsche Bank Aktiengesellschaft boosted their target price on CME Group from $200.00 to $218.00 in a research report on Thursday, February 9th. Rosenblatt Securities restated a “sell” rating and issued a $161.00 price target on shares of CME Group in a research report on Wednesday, April 5th. Citigroup dropped their price objective on shares of CME Group from $214.29 to $210.00 in a research note on Thursday, January 12th. Finally, Piper Sandler lowered their target price on shares of CME Group from $270.00 to $250.00 and set an “overweight” rating for the company in a report on Monday, December 19th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $219.83.

CME Group Profile

(Get Rating)

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.